TBTC Study 29: Evaluation of a Rifapentine-Containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis.
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2014
At a glance
- Drugs Rifapentine (Primary) ; Rifampicin
- Indications Pulmonary tuberculosis
- Focus Adverse reactions; Therapeutic Use
- 07 May 2014 Trial status changed to completed as reported by ClinicalTrials.gov.
- 22 May 2013 Interim tolerability results presented at the 109th International Conference of the American Thoracic Society.
- 07 May 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History